Rights issue record date fixed at November 11, 2026; price INR 860 per share, ratio 5:12
Evonile Pharma's Rights Issue Committee fixed November 11, 2026 as the record date for a rights issue of 1,02,87,832 partly paid equity shares at INR 860 each, in the ratio 5:12.
By ScoutQuest · · 2 min read
- Issue price
- INR 860 per rights equity share
- Entitlement ratio
- 5 rights equity shares for every 12 fully paid-up equity shares held
- Record date
- November 11, 2026
What the committee decided
The Rights Issue Committee met on November 04, 2026 and fixed the record date for the company's rights issue as Wednesday, November 11, 2026. Shareholders holding shares on that date will be eligible for rights entitlements.
Issue terms
- 1,02,87,832 partly paid equity shares proposed to be issued
- Issue price: INR 860 per rights equity share
- Issue size: INR 8,847.54 million
- Entitlement: 5 rights equity shares for every 12 fully paid-up equity shares held
Partly paid, so payment comes in two parts
- INR 645.00 per rights equity share on application
- INR 215.00 per rights equity share on the first and final call
This means an applicant pays only part of the price now; the rest becomes payable when the company makes the call.
Dates to note
- Last date for credit of rights entitlement: November 12, 2026
- Issue opens: November 19, 2026
- Last date for on-market renunciation of rights entitlement: November 27, 2026
- Issue closes: December 03, 2026
- Finalisation of basis of allotment and date of allotment (on or about): December 04, 2026
- Credit of rights equity shares (on or about): December 07, 2026
- Listing (on or about): December 09, 2026
How the share count changes
- Equity shares before the issue: 24,690,797
- Equity shares after the issue, assuming full subscription for and allotment of the rights entitlements: 34,978,629
What a retail shareholder should keep in mind
- Eligibility is decided by holdings on the record date, November 11, 2026.
- Entitlement is calculated at 5 for every 12 shares; fractional entitlements are rounded down and ignored.
- Because the shares are partly paid, applying is also a commitment to pay the balance of INR 215.00 per share when the first and final call is made.
- Shareholders who do not want to subscribe can renounce their entitlements on-market up to November 27, 2026.
- With more shares being issued, a shareholder who does not apply holds a smaller percentage of the company than before.
Also from Evonile Pharma
Rights Issue Record Date Fixed at November 11, 2026; 5:12 Entitlement at INR 860 per Share
4 Nov 2026
Board approves rights issue of partly paid equity shares up to ₹ 9,000 million
4 Nov 2026
Audio recording of earnings call on Q2 and half-year results put on company website
4 Nov 2026
More numbers
- Issue price per rights equity shareINR 860 /-
- Total number of securities proposed to be issued1,02,87,832
- Issue sizeINR 8,847.54/- Million
- Rights entitlement ratio5 Rights Equity Shares to each 12 fully paid-up Equity shares held (5:12)
- Amount payable on application per rights equity share₹ 645.00 per Rights Equity Share
- Amount payable on first and final call per rights equity share₹ 215.00 per Rights Equity Share
- Outstanding equity shares prior to the rights issue24,690,797 Equity Shares
- Outstanding equity shares after the rights issue (full subscription)34,978,629 Equity Shares
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.